Involvement of heparanase in vaginal and cesarean section deliveries

Thrombosis Research

Volumn 126, Issue 6, 2010, Pages

  Nadir, Yona ^a   Kenig, Yael ^b   Drugan, Arie ^b   Zcharia, Eyal ^c   Brenner, Benjamin ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b Hadassah Hebrew University Medical Center ^*  (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Heparanase; IUGR; Pregnancy; TFPI

Indexed keywords

BETA ACTIN; HEPARANASE; PLACENTA PROTEIN 5; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; VASCULOTROPIN A;

ADULT; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; CHORION VILLUS; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; ENZYME RELEASE; FEMALE; FETUS; GENE EXPRESSION; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; LUNG PARENCHYMA; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN FOLDING; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SKIN CULTURE; THIRD TRIMESTER PREGNANCY; VAGINAL DELIVERY;

ADULT; ANIMALS; CERVIX UTERI; CESAREAN SECTION; FEMALE; GLUCURONIDASE; GLYCOPROTEINS; HUMANS; LABOR, OBSTETRIC; LIPOPROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PLACENTA; PREGNANCY; VAGINA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78649738523     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.09.007     Document Type: Article

References (27)

1. N. Lanir, A. Aharon, and B. Brenner Procoagulant and anticoagulant mechanisms in human placenta Semin Thromb Hemost 29 2003 175 184
2. C. Freeman, and C.R. Parish Human platelet heparanase: purification, characterization and catalytic activity Biochem J 330 1998 1341 1350
3. D.S. Pikas, J.P. Li, and I. Vlodavsky Substrate specificity of heparanases from human hepatoma and platelets J Biol Chem 273 1998 18770 18777
4. C.R. Parish, C. Freeman, and M.D. Hulett Heparanase: a key enzyme involved in cell invasion Biochim Biophys Acta 1471 2001 M99 M108
5. I. Vlodavsky, and Y. Friedmann Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis J Clin Invest 108 2001 341 347 (Pubitemid 32730777)
6. L.A. Dempsey, G.J. Brunn, and J.L. Platt Heparanase, a potential regulator of cell-matrix interactions Trends Biochem Sci 25 2000 349 351
7. O. Goldshmidt, E. Zcharia, and M. Cohen Heparanase mediates cell adhesion independent of its enzymatic activity FASEB J 17 2003 1015 1025
8. S. Gingis-Velitski, A. Zetser, and M.Y. Flugelman Heparanase induces endothelial cell migration via protein kinase B/Akt activation J Biol Chem 279 2004 23536 23541
9. A. Zetser, Y. Bashenko, and E. Edovitsky Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation Cancer Res 66 2006 1455 1463
10. Y. Nadir, I. Henig, and I. Naroditzky Involvement of Heparanase in early pregnancy losses Thromb Res 125 2010 e251 e257
11. Y. Nadir, B. Brenner, and A. Zetser Heparanase induces tissue factor expression in vascular endothelial and cancer cells J Thromb Haemost 4 2006 2443 2451
12. Y. Nadir, B. Brenner, and S. Gingis-Velitski Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells Thromb Haemost 99 2008 133 141
13. A. Zetser, F. Levy-Adam, and V. Kaplan Processing and activation of latent heparanase occurs in lysosomes J Cell Sci 117 2004 2249 2258
14. E. Zcharia, S. Metzger, and T. Chajek-ShaulL Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior FASEB J 18 2004 252 263
15. E. Zcharia, J. Jia, and X. Zhang Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases PLoS ONE 4 2009 e5181
16. C. McCarthy, F.E. Cotter, and S. McElwaine Altered gene expression patterns in intrauterine growth restriction: potential role of hypoxia Am J Obstet Gynecol 196 70 2007 e1 e6
17. K.M. Fetalvero, P. Zhang, and M. Shyu Prostacyclin primes pregnant human myometrium for an enhanced contractile response in parturition J Clin Invest 118 2008 3966 3979
18. R. Haimov-Kochman, Y. Friedmann, and D. Prus Localization of heparanase in normal and pathological human placenta Mol Hum Reprod 8 2002 566 573
19. R. Goshen, A.A. Hochberg, and G. Korner Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts Mol Hum Reprod 2 1996 679 684
20. K. Udagawa, H. Yasumitsu, and M. Esaki Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts Placenta 23 2002 145 153
21. M.P. Herman, G.K. Sukhova, and W. Kisiel Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis J Clin Invest 107 2001 1117 1126
22. H.T. Salem, J.G. Westergaard, and P. Hindersson Maternal serum levels of placental protein 5 in complications of late pregnancy Obstet Gynecol 59 1982 467 471
23. E. Sgambati, M. Marini, and G.D. Zappoli Thyrion VEGF expression in the placenta from pregnancies complicated by hypertensive disorders BJOG 111 2004 564 570
24. E. Geva, D.G. Ginzinger, and C.J. Zaloudek Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2 J Clin Endocrinol Metab 87 2002 4213 4224
25. E. Brogi, T. Wu, and A. Namiki Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only Circulation 90 1994 649 652
26. A. Elati, and A.D. Weeks The use of misoprostol in obstetrics and gynaecology BJOG 116 2009 61 69
27. S.Q. Wei, Z.C. Luo, and H. Xu The effect of early oxytocin augmentation in labor: a meta-analysis Obstet Gynecol 114 2009 641 649